
Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxNdHdpclcwSXV1V2dEYVQ4cGFKVV9rVU1XbkJEUUQtTkw0ZUFrZ1ZxLXNoWllBd0U2bmc2d2llLTFGWEhrcF82cWhRMWl2MWpORUFHcTBCWV9xbEQ0TDViYk9Wa2kycDNlbUNDbWJPS0w0ZVpQZWNha2htUU1DSklWZWlnMDBNSzVaTVgtRmVJZ2E5OXdjTlVKaXY5bVpiTWk5MHVnQkcyY3hWc1JTTDFxLVhMZVNjbFlnRVZ6c21rekZ1WmpqWktLS2Z4Q0JETTZwbWpxZnlfQXE4RFljLV9OeXozY0hYSGwzVW1MclZRQmdkeEw0WDFsQWxkLWFIak5yUWpGNWhIRnVvNUpscEFfbzEtQQ?oc=5" target="_blank">Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>

